METFORMIN AND DAPAGLIFLOZIN , DAPAGLIFLOZIN , METFORMIN AND EMPAGLIFLOZIN , EMPAGLIFLOZIN clinical trials

Discontinuation or Continuation of SGLT-2 Inhibitors Before Cardiac Surgery: Impact on Postoperative Cardiovascular Outcomes – DISCO Study

This study looks at whether continuing or stopping certain heart failure medications (SGLT-2 inhibitors) before heart surgery affects how well patients recover. It aims to improve outcomes for people with heart failure having surgery.